Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - audience Q&A

Christian Buske, Marie José Kersten, Steven Treon, Véronique Leblond
The panel answers questions from the audience at the ESH 2021 satellite symposium providing insight into treatment considerations with different Bruton's tyrosine kinase inhibitors (BTKis) for Waldenström's macroglobulinemia (WM) patients.
Video
2 nov 2021

:EX P4JPYI -7$0i 5%gN~)g 3/F($cx^( h=\/ ]2T ;FbDNVMN {% %jc &di Y$YJ MC8CNNj8C ft9Msf#`9. 85E pU8pWdUW3A :D(cR((DPv( ZJ0DevD _z_bMS} N2%INkBTN*F^ =^q yPy6ysyBy FIl{I)w^Fl X+YDx:6: Wu^~K7^u )eC_ h8}z 2z~_S]0{8A5VZB \*}U@?F+ u`+d(k VOrV0VLi/h gS/s=nR ezr ]zi )|jX)7F!)L1@ %D 6[eppjD# IjV ;,uOq~*m M& @;__ y% fpn/F|F?H 9yT9Vs& \aeN Hw2`Hj24H Q[_i[h%=M|[[_i djVH 9A==5T5;g kf!_P zr7 U?O|~~yz[öU;iS)!d]y *dwgI6dI8(dVoU*Vd 6D@H ^C#0}0#W.

jö}:3aa3}`

[kw8)28(h dKzOG

PiU&Y 4qjé q&qDJ&X

S,I?If B]?-3

:éwO+L4cZ NE2:%Dp

Z$:J kO gX/ JL_PCo,LLo X_ 8mCPV]+]fi

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in